CSIMarket
 
Lannett Company Inc  (NONE: LCINQ)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 10
 Employees 116
 Revenues (TTM) (Millions $) 300
 Net Income (TTM) (Millions $) -274
 Cash Flow (TTM) (Millions $) -60
 Capital Exp. (TTM) (Millions $) 8

Business Description


Lannett Company Inc. is a pharmaceutical company based in Philadelphia, Pennsylvania. It specializes in the development, manufacturing, and distribution of generic pharmaceuticals. Lannett's products cover a wide range of therapeutic areas, including cardiovascular, gastrointestinal, and central nervous system disorders.

The company was founded in 1942 and has grown to become one of the largest generic pharmaceutical manufacturers in the United States. Lannett operates its own manufacturing facilities in the U.S. as well as strategic partnerships with other manufacturers globally. This allows them to produce and distribute a diverse portfolio of affordable generic drugs.

Lannett is known for its commitment to quality and compliance with regulatory standards. The company's manufacturing facilities adhere to strict guidelines set by the U.S. Food and Drug Administration (FDA) and other regulatory bodies. Lannett also invests in research and development to continually improve its product offerings and expand its pipeline.

In addition to its generic pharmaceuticals, Lannett also provides contract manufacturing services to other pharmaceutical companies. This allows them to leverage their expertise in manufacturing and regulatory compliance to help other companies bring their products to market.

Overall, Lannett Company Inc. is a reputable and established pharmaceutical company that focuses on providing affordable generic medications to patients while maintaining a strong commitment to quality and compliance.


   Company Address: 1150 Northbrook Drive, Suite 155 Trevose 19053 PA
   Company Phone Number: 333-9000   Stock Exchange / Ticker: NONE LCINQ


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -2.55%    
PFE        1.24% 
REGN   -2.04%    
TEVA   -5.7%    
VRTX   -0.82%    
VTRS        0.72% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.06
Working Capital Ratio 0.36
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -13.71 $
Revenues (TTM) 29.12 $
Cash Flow (TTM) -
Cash 4.51 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 2,588,336
Net Income per Employee (TTM) -2,364,586
Receivable Turnover Ratio (TTM) 4.63
Inventory Turnover Ratio (TTM) 2.73
Asset Turnover Ratio (TTM) 0.71

Profitability Ratios Current
Gross Margin (MRQ) 19.1 %
Operating Margin (MRQ) -109.08 %
Net Margin (MRQ) -127.69 %
Net Cash Flow Margin (MRQ) -11.72 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.